Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole for prevention of ovarian hyperstimulation syndrome
jRCTs041190131Recruiting
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of letrozole in ovarian hyperstimulation syndrome (OHSS). Primary endpoint: Improvement of ovarian hyperstimulation syndrome after intervention. Started Mar 2020; status: recruiting.
02
Drugs
letrozole
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on jRCTs041190131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041190131.